Related Videos

There are currently no news stories for this ticker. Please check back later.

There are currently no press releases for this ticker. Please check back later.

Profile

Neurologix, Inc. is developing treatments for disorders of the brain and central nervous system using gene therapy and other alternative therapies. The Company's initial development efforts are focused on gene therapy for treating Parkinson's disease and epilepsy. Neurologix's core technology, NLX, is currently being tested in a human clinical trial to treat Parkinson's disease.